Why the study?
The clinical implications of underlying plaque characteristics in coronary lesions after newer-generation drug-eluting stent implantation remain unknown.
Does NIRS-derived underlying lipid-rich plaque predict LOCO or POCO in patients with CAD after newer-generation DES implantation?
Does NIRS-derived underlying lipid-rich plaque predict LOCO or POCO in patients with CAD after newer-generation DES implantation?
Answers are grounded in this paper and cite their sources.
Underlying lipid-rich plaque detected by NIRS is not associated with future stent-related or patient-based outcomes after newer-generation DES implantation.
BACKGROUND: Lipid-rich plaque is an important substrate that causes future coronary events. However, the clinical implications of underlying plaque characteristics in coronary lesions after newer-generation drug-eluting stent (DES) implantation remain unknown. METHODS: tertile. RESULTS: and POCO (OR, 1.001; 95% CI, 0.999-1.002; P = 0.30). CONCLUSIONS: is not associated with LOCO or POCO in patients with CAD after newer-generation DES implantation. Our findings suggest that NIRS-derived underlying lipid-rich plaque is not associated with the risk of stent-related events and patient-based outcomes in patients with CAD who have received newer-generation DESs.
No takes yet. Share an insight, caveat, or question.
Murai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: